Biotech took a big tumble in March, and its 30% loss was the worst performing group. Technology issues were also particularly hard hit with 5 of the next 7 worst performers high tech groups.
Apr
05
2000
Scanning The Markets
Subscribe to Advisor Newsletter
Leuthold Advisors Newsletter subscriptions include a no-obligation 14-day trial. Cancel at any time before the 14 days are over and you will not be billed.
Subscribe now